These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 35373634)

  • 21. Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.
    Williams C; Brunskill S; Altman D; Briggs A; Campbell H; Clarke M; Glanville J; Gray A; Harris A; Johnston K; Lodge M
    Health Technol Assess; 2006 Sep; 10(34):iii-iv, ix-xi, 1-204. PubMed ID: 16959170
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Non-invasive imaging software to assess the functional significance of coronary stenoses: a systematic review and economic evaluation.
    Duarte A; Llewellyn A; Walker R; Schmitt L; Wright K; Walker S; Rothery C; Simmonds M
    Health Technol Assess; 2021 Sep; 25(56):1-230. PubMed ID: 34588097
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Spot protein-creatinine ratio and spot albumin-creatinine ratio in the assessment of pre-eclampsia: a diagnostic accuracy study with decision-analytic model-based economic evaluation and acceptability analysis.
    Waugh J; Hooper R; Lamb E; Robson S; Shennan A; Milne F; Price C; Thangaratinam S; Berdunov V; Bingham J
    Health Technol Assess; 2017 Oct; 21(61):1-90. PubMed ID: 29064366
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Health technology assessment report: Computer-assisted Pap test for cervical cancer screening].
    Della Palma P; Moresco L; Giorgi Rossi P
    Epidemiol Prev; 2012; 36(5 Suppl 3):e1-43. PubMed ID: 23139174
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The future for diagnostic tests of acute kidney injury in critical care: evidence synthesis, care pathway analysis and research prioritisation.
    Hall PS; Mitchell ED; Smith AF; Cairns DA; Messenger M; Hutchinson M; Wright J; Vinall-Collier K; Corps C; Hamilton P; Meads D; Lewington A
    Health Technol Assess; 2018 May; 22(32):1-274. PubMed ID: 29862965
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.
    Forbes C; Shirran L; Bagnall AM; Duffy S; ter Riet G
    Health Technol Assess; 2001; 5(28):1-110. PubMed ID: 11701100
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quantifying the Impact of Capacity Constraints in Economic Evaluations: An Application in Precision Medicine.
    Wright SJ; Newman WG; Payne K
    Med Decis Making; 2022 May; 42(4):538-553. PubMed ID: 34694170
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cost effectiveness of self-monitoring of blood glucose (SMBG) for patients with type 2 diabetes and not on insulin: impact of modelling assumptions on recent Canadian findings.
    Tunis SL
    Appl Health Econ Health Policy; 2011 Nov; 9(6):351-65. PubMed ID: 21892840
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Systematic Review of Health Economic Evaluations of Diagnostic Biomarkers.
    Oosterhoff M; van der Maas ME; Steuten LM
    Appl Health Econ Health Policy; 2016 Feb; 14(1):51-65. PubMed ID: 26334528
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Practical Guide to Modeling and Conducting a Cost-Effectiveness Analysis of Companion Biomarker Tests for Targeted Therapies Using R: Tutorial Paper.
    Seo MK; Strong M
    Pharmacoeconomics; 2021 Dec; 39(12):1373-1381. PubMed ID: 34414545
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Systematic Review of Model-Based Economic Evaluations of Treatments for Alzheimer's Disease.
    Hernandez L; Ozen A; DosSantos R; Getsios D
    Pharmacoeconomics; 2016 Jul; 34(7):681-707. PubMed ID: 26899832
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tumour profiling tests to guide adjuvant chemotherapy decisions in early breast cancer: a systematic review and economic analysis.
    Harnan S; Tappenden P; Cooper K; Stevens J; Bessey A; Rafia R; Ward S; Wong R; Stein RC; Brown J
    Health Technol Assess; 2019 Jun; 23(30):1-328. PubMed ID: 31264581
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Estimation of diagnostic accuracy of a combination of continuous biomarkers allowing for conditional dependence between the biomarkers and the imperfect reference-test.
    García Barrado L; Coart E; Burzykowski T
    Biometrics; 2017 Jun; 73(2):646-655. PubMed ID: 27598904
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modeling Approaches in Cost-Effectiveness Analysis of Disease-Modifying Therapies for Relapsing-Remitting Multiple Sclerosis: An Updated Systematic Review and Recommendations for Future Economic Evaluations.
    Hernandez L; O'Donnell M; Postma M
    Pharmacoeconomics; 2018 Oct; 36(10):1223-1252. PubMed ID: 29971666
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnostic management strategies for adults and children with minor head injury: a systematic review and an economic evaluation.
    Pandor A; Goodacre S; Harnan S; Holmes M; Pickering A; Fitzgerald P; Rees A; Stevenson M
    Health Technol Assess; 2011 Aug; 15(27):1-202. PubMed ID: 21806873
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mental health care system optimization from a health-economics perspective: where to sow and where to reap?
    Lokkerbol J; Weehuizen R; Mavranezouli I; Mihalopoulos C; Smit F
    J Ment Health Policy Econ; 2014 Jun; 17(2):51-60. PubMed ID: 25153093
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Elucigene FH20 and LIPOchip for the diagnosis of familial hypercholesterolaemia: a systematic review and economic evaluation.
    Sharma P; Boyers D; Boachie C; Stewart F; Miedzybrodzka Z; Simpson W; Kilonzo M; McNamee P; Mowatt G
    Health Technol Assess; 2012; 16(17):1-266. PubMed ID: 22469073
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Positron emission tomography/computerised tomography imaging in detecting and managing recurrent cervical cancer: systematic review of evidence, elicitation of subjective probabilities and economic modelling.
    Meads C; Auguste P; Davenport C; Małysiak S; Sundar S; Kowalska M; Zapalska A; Guest P; Thangaratinam S; Martin-Hirsch P; Borowiack E; Barton P; Roberts T; Khan K
    Health Technol Assess; 2013 Mar; 17(12):1-323. PubMed ID: 23537558
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modeling companion diagnostics in economic evaluations of targeted oncology therapies: systematic review and methodological checklist.
    Doble B; Tan M; Harris A; Lorgelly P
    Expert Rev Mol Diagn; 2015 Feb; 15(2):235-54. PubMed ID: 25142227
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.